<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We analyzed data from 388 subjects with Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo> reported to the International Fanconi <z:hpo ids='HP_0001903'>Anemia</z:hpo> Registry (IFAR) </plain></SENT>
<SENT sid="1" pm="."><plain>Of those, 332 developed hematologic abnormalities at a median age of 7 years (range, birth to 31 years) </plain></SENT>
<SENT sid="2" pm="."><plain>Actuarial risk of developing hematopoietic abnormalities was 98% (95% confidence interval, 93% to 99%) by 40 years of age </plain></SENT>
<SENT sid="3" pm="."><plain>Common hematologic abnormalities were <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>These were often associated with decreased bone marrow (BM) cellularity (75% of cases studied) </plain></SENT>
<SENT sid="5" pm="."><plain>Clonal cytogenetic abnormalities developed in 23 of 68 persons with BM failure who had adequate studies </plain></SENT>
<SENT sid="6" pm="."><plain>Actuarial risk of clonal cytogenetic abnormalities during BM failure was 67% (47% to 87%) by 30 years of age </plain></SENT>
<SENT sid="7" pm="."><plain>Fifty-nine subjects developed <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) or <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="8" pm="."><plain>Actuarial risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> was 52% (37% to 67%) by 40 years of age </plain></SENT>
<SENT sid="9" pm="."><plain>Risk was higher in persons with than in those without a prior clonal cytogenetic abnormality (3% [0% to 9%] v 35% [0% to 79%]; P = .006) </plain></SENT>
<SENT sid="10" pm="."><plain>One hundred twenty persons died of hematologic causes including BM failure, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and treatment related complications </plain></SENT>
<SENT sid="11" pm="."><plain>Actuarial risk of <z:hpo ids='HP_0011420'>death</z:hpo> from hematologic causes was 81% (67% to 90%) by 40 years of age </plain></SENT>
</text></document>